24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Arkin
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:54
War, what is it good for? The shekel
15:23
Palo Alto Networks completes $400 million acquisition of Koi
12:42
Wiz and Cyberstarts take over Landmark Tower B in major Tel Aviv leasing deal
12:27
OurCrowd sued over alleged preferential unit conversion deal
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli chip startup DustPhotonics in advanced sale talks worth hundreds of millions
2
Cisco in advanced talks to acquire AI security startup Astrix for up to $350 million
3
JPMorgan sues Aleph over Frank fraud fallout
4
GPS disruptions persist across Israel despite ceasefire with Iran
5
Palo Alto Networks founder Nir Zuk moves into U.S. banking with Liberty Bank bid
More news
Arkin
2 stories about Arkin
Arkin raises $100 million biotech fund focused on early clinical science
12.01.26
|
CTech
Arkin Bio Ventures III emphasizes scientific rigor amid shifting biotech markets.
Censa Pharmaceuticals Signs Joint Development Agreement with Biotech Company Retrophin
07.01.18
|
Lilach Baumer
Censa, a company developing treatments for orphan metabolic diseases, is a portfolio company of Israel-based Arkin Bio Ventures
